Clinical Trials
4 trialsNCT01420770 2025-03-05
Phase 2 Study of SAR302503 in Patients With Myelofibrosis
Bristol-Myers Squibb
Phase 2 Completed
NCT01420783 2025-03-05
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Bristol-Myers Squibb
Phase 2 Completed
NCT01437787 2025-03-05
JAKARTA
Bristol-Myers Squibb
Phase 3 Completed
NCT01523171 2025-03-05
JAKARTA2
Bristol-Myers Squibb
Phase 2 Completed